How short-term smoking abstinence changes brain pain processing in people who smoke with or without chronic low back pain
Official title: Neural Correlates and Behavioral Impact of Withdrawal-induced Hyperalgesia Among People Who Smoke With and Without Chronic Pain
Run by Duke University · NCT06983678 · Data updated 2026-11-12
This will test whether 24-hour smoking abstinence increases pain sensitivity in the brain and makes quitting harder for adults who smoke, including those with chronic low back pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 65 Years |
| Sex | All |
| Enrollment | 132 (estimated) |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Status | Recruiting |
| Started | November 4, 2025 |
| Main results expected | March 31, 2030 |
| Study ends | March 31, 2030 |
| Registry record updated | November 20, 2025 |
| Trial ID | NCT06983678 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21–65 who smoke at least 10 cigarettes per day for over 2 years and either have chronic non-cancer low back pain for ≥6 months or no chronic pain, who can undergo MRI and use a smartphone for EMA.
✕Probably not a fit
People actively trying to quit, those using opioids, with MRI contraindications, significant uncontrolled medical or recent substance use disorders, or other exclusionary conditions would likely be ineligible and may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who smoke (with chronic non-cancer low back pain or without chronic pain) will complete sensory training and two fMRI sessions in a within-subject crossover design: one after 24 hours of abstinence and one after smoking as usual. During each scan participants receive painful heat stimuli and provide pain ratings while craving, withdrawal, and physiological measures are recorded. After scanning participants install EMA software on their smartphone, complete baseline ecological momentary assessments, and then attempt to abstain while continuing EMA with biochemical verification. The study compares brain activation and behavioral responses across smoking and abstinent conditions to see if withdrawal-induced hyperalgesia interferes with quit attempts.
Why it matters
Potential benefit: If successful, the results could inform targeted interventions to help people with chronic pain who smoke to quit and better manage pain.
How similar studies have gone: Prior studies show nicotine withdrawal can increase pain and fMRI research has mapped pain-related brain responses, but applying these methods specifically to withdrawal-induced hyperalgesia in chronic pain populations combined with real-world EMA is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. History of chronic non-cancer low back pain with duration ≥ 6 months OR no history of chronic pain; 2. age 21-65; 3. smoking of at least 10 cig/day for \> 2 years; 4. have an iPhone or Android smartphone capable of running the EMA software Exclusion Criteria: 1. pain complaint specifically due to cancer, rheumatoid arthritis, or complex regional pain syndrome; 2. actively taking steps to quit smoking; 3. inability to attend all required experimental sessions; 4. significant health problems, such as chronic hypertension, emphysema, seizure disorder, history of significant heart problems; 5. conditions that would make MRI scanning unsafe (e.g., metal implants, claustrophobia) 6. use of opioids within the past 90 days 7. past year alcohol or substance use disorder 8. positive urine test for illegal drugs (other than marijuana); 9. daily use of alcohol or marijuana; 10. lifetime history of psychotic disorder, or current unstable psychiatric disorder; 11. regular use of non-cigarette tobacco products or electronic cigarettes; 12. major surgery within the past 6 months or planned surgery within the timeframe of the study; 13. breath alcohol level \> 0.0 (participants failing for BAL will be allowed to rescreen once); 14. recently quit smoking for \> 3 days; 15. pregnancy or planning to become pregnant; 16. any factors that at the discretion of the investigators would adversely affect the participant or integrity of the study (e.g., ongoing legal action or disability claim regarding pain, uncontrolled psychiatric disorder, head/neck injury, use of certain medications)
Where it's running
-
Duke North Pavilion
Durham, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Maggie Sweitzer, Ph.D. — Duke University
- Study coordinator: Clinical Research Coordinator
- Email: sweitzerlab@duke.edu
- Phone: 919-907-9955
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of Low Nicotine Cigarettes on Chronic Pain and Cravings
This study tests if switching to very low nicotine cigarettes can help people with chronic pain who smoke and are being treated for opioid addiction by reducing their cravings and pain levels.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.